NIBEC Co., Ltd. (KOSDAQ: A138610)
Health Care · Biotechnology · KR
₩15,650.00
-2.07% today · -61.0% 1Y
NIBEC Co., Ltd. (KOSDAQ: A138610) operates in the Biotechnology industry within the Health Care sector. The company is valued at $132.33M.
Over the last twelve months the share price has lost 61.0%, trading between 11.23K and 54.30K.
Tweenvest scores NIBEC Co., Ltd. across four factors: quality 78/100, value 59/100. Its strongest factor is quality.
A138610 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $132.33M
- Revenue (TTM)
- $14.60M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.62
- 52-week high
- ₩54,300.00
- 52-week low
- ₩11,230.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.37M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NeoImmuneTech, Inc.KOSDAQ: A950220 | $139.14M | ₩1,892.00 | -4.69% |
| Korro Bio, Inc.NasdaqCM: KRRO | $137.98M | $9.37 | -7.78% |
| Armata Pharmaceuticals, Inc.NYSEAM: ARMP | $134.97M | $3.58 | -1.38% |
| Innate Pharma S.A.ENXTPA: IPH | $134.19M | €1.28 | -1.54% |
| StemCyte International, Ltd.TWSE: 4178 | $132.32M | NT$19.60 | +8.89% |
| Saniona AB (publ)OM: SANION | $132.11M | Skr9.57 | -0.26% |
| Orthocell LimitedASX: OCC | $131.16M | AU$0.69 | -9.21% |
| Tenaya Therapeutics, Inc.NasdaqCM: TNYA | $130.12M | $0.57 | -2.55% |
Figures last refreshed Oct 11, 2026.